biomarin
BioMarin is a global biotech company focused on translating genetic discoveries into medicines that address significant unmet medical needs. The company employs a collaborative and innovative environment to develop transformative drugs for patients with rare genetic diseases.
Headquarters
San Rafael, California, United States
Company Size
1001-5000 employees
Founded
1997
BioMarin Pharmaceutical is a global biotechnology company that researches, develops, and commercializes therapies for rare genetic and lysosomal storage diseases. The company has brought medicines to market for conditions such as achondroplasia and severe hemophilia A and focuses on innovative modalities—including gene therapies and biologics—to address high unmet medical needs. BioMarin partners with clinicians, regulators, and patient communities to advance treatments from discovery through global regulatory approval and patient access.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for biomarin.
Chief of Staff to CEO of BridgeBio and GondolaBio
BridgeBio Pharma
Treasury Operations Analyst
Octopus Energy Group
Sr. Director, Pharmacometrics
Kyowa Kirin
Treasury Analyst - Treasury Shared Service Center
Corpay
Sr Associate Treasury
Amgen
Senior Treasury Relationship Manager – Government Banking - NJ
Oracle